These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans. Bleiker TO; Nicolaou N; Traulsen J; Hutchinson PE Br J Dermatol; 2005 Jul; 153(1):103-12. PubMed ID: 16029334 [TBL] [Abstract][Full Text] [Related]
3. Diffuse hair loss: its triggers and management. Harrison S; Bergfeld W Cleve Clin J Med; 2009 Jun; 76(6):361-7. PubMed ID: 19487557 [TBL] [Abstract][Full Text] [Related]
4. The biology of hair. Ebling FJ Dermatol Clin; 1987 Jul; 5(3):467-81. PubMed ID: 3301105 [TBL] [Abstract][Full Text] [Related]
5. Telogen effluvium: hair loss after spinal cord injury. Dahlin PA; George J; Nérette JC Arch Phys Med Rehabil; 1984 Aug; 65(8):485-6. PubMed ID: 6431941 [TBL] [Abstract][Full Text] [Related]
6. Practical management of hair loss. Shapiro J; Wiseman M; Lui H Can Fam Physician; 2000 Jul; 46():1469-77. PubMed ID: 10925761 [TBL] [Abstract][Full Text] [Related]
7. Patients with profuse hair shedding may reveal anagen hair dystrophy: a diagnostic clue of alopecia areata incognita. Quercetani R; Rebora AE; Fedi MC; Carelli G; Mei S; Chelli A; Poli E J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):808-10. PubMed ID: 20946585 [TBL] [Abstract][Full Text] [Related]
9. Distinguishing androgenetic alopecia from chronic telogen effluvium when associated in the same patient: a simple noninvasive method. Rebora A; Guarrera M; Baldari M; Vecchio F Arch Dermatol; 2005 Oct; 141(10):1243-5. PubMed ID: 16230561 [TBL] [Abstract][Full Text] [Related]
10. Telogen effluvium: a clinically useful concept, with traction alopecia as an example. Steck WD Cutis; 1978 Apr; 21(4):543-8. PubMed ID: 639573 [TBL] [Abstract][Full Text] [Related]
11. Hair Loss: Common Causes and Treatment. Phillips TG; Slomiany WP; Allison R Am Fam Physician; 2017 Sep; 96(6):371-378. PubMed ID: 28925637 [TBL] [Abstract][Full Text] [Related]
12. Chronic telogen effluvium is due to a reduction in the variance of anagen duration. Gilmore S; Sinclair R Australas J Dermatol; 2010 Aug; 51(3):163-7. PubMed ID: 20695853 [TBL] [Abstract][Full Text] [Related]
13. Methods of hair loss evaluation in patients with endocrine disorders. Olszewska M; Warszawik O; Rakowska A; Słowińska M; Rudnicka L Endokrynol Pol; 2010; 61(4):406-11. PubMed ID: 20806187 [TBL] [Abstract][Full Text] [Related]
15. Alopecia in women. Thiedke CC Am Fam Physician; 2003 Mar; 67(5):1007-14. PubMed ID: 12643360 [TBL] [Abstract][Full Text] [Related]
16. Telogen effluvium. Harrison S; Sinclair R Clin Exp Dermatol; 2002 Jul; 27(5):389-5. PubMed ID: 12190639 [TBL] [Abstract][Full Text] [Related]
17. Chronic telogen effluvium: a study of 5 patients over 7 years. Sinclair R J Am Acad Dermatol; 2005 Feb; 52(2 Suppl 1):12-6. PubMed ID: 15692504 [TBL] [Abstract][Full Text] [Related]
19. Common hair loss disorders. Springer K; Brown M; Stulberg DL Am Fam Physician; 2003 Jul; 68(1):93-102. PubMed ID: 12887115 [TBL] [Abstract][Full Text] [Related]